logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Prostaglandin Analog class drugs

    FiltersReset Filters
    20 results

    • bimatoprost

      (bimatoprost)
      Alembic Pharmaceuticals Inc.
      Usage: Bimatoprost ophthalmic solution, 0.03% is indicated for the treatment of hypotrichosis of the eyelashes, promoting increased growth in length, thickness, and darkness.

    • bimatoprost

      (Bimatoprost)
      Alembic Pharmaceuticals Inc.
      Usage: Bimatoprost ophthalmic solution, 0.03%, is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    • bimatoprost

      (Bimatoprost)
      Fosun Pharma USA Inc.
      Usage: Bimatoprost ophthalmic solution, 0.03%, is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    • bimatoprost

      (Bimatoprost)
      Sandoz Inc
      Usage: Bimatoprost ophthalmic solution, 0.03% is indicated for the treatment of hypotrichosis of the eyelashes, promoting increased growth in length, thickness, and darkness.

    • carboprost tromethamine

      (carboprost tromethamine)
      Amneal Pharmaceuticals LLC
      Usage: Carboprost tromethamine injection is indicated for abortion in the 13th to 20th weeks of gestation, addressing cases such as failed expulsion, premature rupture of membranes, and requirement for repeat drug instillation. It is also used to treat postpartum hemorrhage due to uterine atony unresponsive to conventional management.

    • carboprost tromethamine

      (CARBOPROST TROMETHAMINE)
      Alembic Pharmaceuticals Limited
      Usage: Carboprost tromethamine injection is indicated for abortion between the 13th and 20th weeks of gestation, addressing issues like fetal expulsion failure, premature ruptured membranes, and repeated drug administration needs. It is also used to treat postpartum hemorrhage due to uterine atony refractory to conventional treatments.

    • carboprost tromethamine

      (CARBOPROST TROMETHAMINE)
      Alembic Pharmaceuticals Inc.
      Usage: Carboprost tromethamine injection is indicated for second-trimester abortion (weeks 13-20) and for treating postpartum hemorrhage due to uterine atony unresponsive to other treatments. It is effective in cases of failed expulsion, premature rupture of membranes, or when additional drug administration is necessary.

    • carboprost tromethamine

      (carboprost tromethamine)
      SOLA Pharmaceuticals, LLC
      Usage: Carboprost tromethamine injection is indicated for aborting pregnancies between the 13th and 20th weeks, addressing complications like failed expulsion or ruptured membranes. It is also used to treat postpartum hemorrhage due to uterine atony that hasn't responded to standard treatments, helping to control life-threatening bleeding.

    • durysta

      (bimatoprost)
      Allergan, Inc.
      Usage: DURYSTA® (bimatoprost intracameral implant) is indicated for reducing intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT).

    • edex

      (alprostadil)
      ENDO USA, Inc.
      Usage: Edex® is indicated for treating erectile dysfunction stemming from various causes, including neurogenic, vasculogenic, psychogenic, or mixed origins.